The DOI matches its Crossref record; 91 of the 94 references it cites were found in a registry or an index.
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Abstract
In this review we provide an up to date snapshot of nanomedicines either currently approved by the US FDA, or in the FDA clinical trials process. We define nanomedicines as therapeutic or imaging agents which comprise a nanoparticle in order to control the biodistribution, enhance the efficacy, or otherwise reduce toxicity of a drug or biologic. We identified 51 FDA-approved nanomedicines that met this definition and 77 products in clinical trials, with ~40% of trials listed in clinicaltrials.gov started in 2014 or 2015. While FDA approved materials are heavily weighted to polymeric, liposomal, and nanocrystal formulations, there is a trend towards the development of more complex materials comprising micelles, protein-based NPs, and also the emergence of a variety of inorganic and metallic particles in clinical trials. We then provide an overview of the different material categories represented in our search, highlighting nanomedicines that have either been recently approved, or are already in clinical trials. We conclude with some comments on future perspectives for nanomedicines, which we expect to include more actively-targeted materials, multi-functional materials ("theranostics") and more complicated materials that blur the boundaries of traditional material categories. A key challenge for researchers, industry, and regulators is how to classify new materials and what additional testing (e.g. safety and toxicity) is required before products become available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to promising outcomes from animal studies, colloidal carriers are now moving into clinical trials in humans (71, 330)”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [71]
Citations
Cites
1 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gerçel-Taylor, Ç. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,333
RetractedUnderstanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,996
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Chaudhuri, R. G., & Paria, S. (2011) · Chemical Reviews · doi:10.1021/cr100449n · Cited by 3,682
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El‐Sayed, M. A. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15237h · Cited by 3,659
Research works printed but not linked: 2
- Duncan R, Sat YN. Tumour targeting by enhanced permeability and retention (EPR) effect. Ann Oncol. 1998;9:39. · DOI
- Cures P. Neglected disease research and development: is the global financial crisis changing R&D. London: Policy Cures; 2011.
Cited by
Sorted by citations
Items 201–300 of 1,006
Branched and Dendritic Polymer Architectures: Functional Nanomaterials for Therapeutic Delivery
Cook, A. B., & Perrier, S. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201901001 · Cited by 164
Li, X., Wang, B., Zhou, S., Chen, W., Chen, H., Liang, S., Zheng, L., Yu, H., Chu, R., Wang, M., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00599-1 · Cited by 162
Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections
Sánchez, A., Mejía, S. P., & Orozco, J. (2020) · Molecules · doi:10.3390/molecules25163760 · Cited by 165
Environment sensitive hydrogels for drug delivery applications
Qureshi, D., Nayak, S. K., Maji, S., Anis, A., Kim, D., & Pal, K. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.109220 · Cited by 159
Zhong, X., Wang, X., Li, J., Hu, J., Cheng, L., & Yang, X. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.213828 · Cited by 159
Nonequilibrium Dynamics of Magnetic Nanoparticles with Applications in Biomedicine
Shasha, C., & Krishnan, K. M. (2020) · Advanced Materials · doi:10.1002/adma.201904131 · Cited by 162
Drug nanocrystals – Versatile option for formulation of poorly soluble materials
Peltonen, L., & Hirvonen, J. J. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.005 · Cited by 157
Lee, Y.-W., Luther, D. C., Goswami, R., Jeon, T., Clark, V., Elia, J. L., Gopalakrishnan, S., & Rotello, V. M. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b12759 · Cited by 161
Bunker, A., & Róg, T. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.604770 · Cited by 162
Straehla, J. P., Hajal, C., Safford, H. C., Offeddu, G. S., Boehnke, N., Dacoba, T. G., Wyckoff, J. B., Kamm, R. D., & Hammond, P. T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118697119 · Cited by 164
Ahmad, A., Imran, M., & Sharma, N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112463 · Cited by 170
Agha, A., Waheed, W., Stiharu, I. G., Nerguizian, V., Destgeer, G., Abu‐Nada, E., & Alazzam, A. (2023) · Discover Nano · doi:10.1186/s11671-023-03792-x · Cited by 162
Morphological/nanostructural control toward intrinsically stretchable organic electronics
Ma, R., Chou, S., Xie, Y., & Pei, Q. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00834e · Cited by 157
Advances in Lipid and Metal Nanoparticles for Antimicrobial Peptide Delivery
Makowski, M., Silva, Í. C., do Amaral, C. P., Gonçalves, S., & Santos, N. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110588 · Cited by 158
Sustained Drug Release from Smart Nanoparticles in Cancer Therapy: A Comprehensive Review
Bai, X., Smith, Z., Wang, Y., Butterworth, S., & Tirella, A. (2022) · Micromachines · doi:10.3390/mi13101623 · Cited by 166
Light-responsive nanomedicine for biophotonic imaging and targeted therapy
Son, J., Yi, G., Yoo, J., Park, C., Koo, H., & Choi, H. S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.002 · Cited by 156
Polymeric Engineering of Nanoparticles for Highly Efficient Multifunctional Drug Delivery Systems
Fortuni, B., Inose, T., Ricci, M., Fujita, Y., Zundert, I. V., Masuhara, A., Fron, E., Mizuno, H., Latterini, L., Rocha, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39107-3 · Cited by 158
Schuemann, J., Bagley, A. F., Berbeco, R. I., Bromma, K., Butterworth, K. T., Byrne, H. L., Chithrani, D. B., Cho, S. H., Cook, J. R., Favaudon, V., et al. (2020) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab9159 · Cited by 165
Triptolide: reflections on two decades of research and prospects for the future
Tong, L., Zhao, Q., Datan, E., Lin, G.-Q., Minn, I., Pomper, M. G., Yu, B., Romo, D., He, Q., & Liu, J. O. (2020) · Natural Product Reports · doi:10.1039/d0np00054j · Cited by 156
Zeng, M., Guo, D., Fernández‐Varo, G., Zhang, X., Fu, S., Ju, S., Yang, H., Liu, X., Wang, Y., Zeng, Y., et al. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00882 · Cited by 162
Haumann, R., Videira, J. C., Kaspers, G. J. L., van Vuurden, D. G., & Hulleman, E. (2020) · CNS Drugs · doi:10.1007/s40263-020-00766-w · Cited by 163
Jeong, H., Choi, E., Ellis, E., & Lee, T. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00557a · Cited by 158
Nanomaterials meet zebrafish: Toxicity evaluation and drug delivery applications
Jia, H., Zhu, Y., Duan, Q., Chen, Z., & Wu, F. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.022 · Cited by 158
MXenes for Cancer Therapy and Diagnosis: Recent Advances and Current Challenges
Iravani, S., & Varma, R. S. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01763 · Cited by 153
Bejarano, J., Navarro-Márquez, M., Morales-Zavala, F., Morales, J. O., García‐Carvajal, I., Araya, E., Flores, Y., Verdejo, H., Castro, P., Lavandero, S., et al. (2018) · Theranostics · doi:10.7150/thno.26284 · Cited by 160
Twenty-five years of polymersomes: lost in translation?
Matoori, S., & Leroux, J. (2020) · Materials Horizons · doi:10.1039/c9mh01669d · Cited by 152
Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms
Birk, S. E., Boisen, A., & Nielsen, L. H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.005 · Cited by 156
Nanomedicines for Cancer Therapy: Current status, Challenges and Future Prospects
Bor, G., Azmi, I. D. M., & Yaghmur, A. (2019) · Therapeutic Delivery · doi:10.4155/tde-2018-0062 · Cited by 153
He, Y., Lei, L., Cao, J., Yang, X., Cai, S., Tong, F., Huang, D., Mei, H., Luo, K., Gao, H., et al. (2021) · Science Advances · doi:10.1126/sciadv.aba0776 · Cited by 148
Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy
Lee, S. Y., Kang, M. S., Jeong, W. Y., Han, D., & Kim, K. S. (2020) · Cancers · doi:10.3390/cancers12040940 · Cited by 149
Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
Zottel, A., Paska, A. V., & Jovčevska, I. (2019) · Materials · doi:10.3390/ma12101588 · Cited by 150
Machtakova, M., Thérien‐Aubin, H., & Landfester, K. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00686j · Cited by 150
Souto, E. B., Silva, G. F., Dias-Ferreira, J., Zielinska, A., Ventura, F., Durazzo, A., Lucarini, M., Novellino, E., & Santini, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020146 · Cited by 144
The rationale and emergence of electroconductive biomaterial scaffolds in cardiac tissue engineering
Solazzo, M., O’Brien, F. J., Nicolosi, V., & Monaghan, M. G. (2019) · APL Bioengineering · doi:10.1063/1.5116579 · Cited by 150
The progress and perspective of strategies to improve tumor penetration of nanomedicines
Hu, J., Yuan, X., Wang, F., Gao, H., Liu, X., & Zhang, W. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.11.006 · Cited by 144
Bio-acceptable 0D and 1D ZnO nanostructures for cancer diagnostics and treatment
Ortiz-Casas, B., Galdámez‐Martínez, A., Gutiérrez-Flores, J., Ibañez, A. B., Panda, P. K., Santana, G., de la Vega, H. A., Suar, M., Gutiérrez-Rodelo, C., Kaushik, A. K., et al. (2021) · Materials Today · doi:10.1016/j.mattod.2021.07.025 · Cited by 147
Stimuli-responsive nanoscale drug delivery systems for cancer therapy
Li, L., Yang, W., & Xu, D. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1519029 · Cited by 143
Jabir, M. S., Saleh, Y. M., Sulaiman, G. M., Yaseen, N. Y., Sahib, U. I., Dewir, Y. H., Alwahibi, M. S., & Soliman, D. A. (2021) · Nanomaterials · doi:10.3390/nano11020384 · Cited by 143
Recent Progress and Trends in X-ray-Induced Photodynamic Therapy with Low Radiation Doses
He, L., Yu, X., & Li, W. (2022) · ACS Nano · doi:10.1021/acsnano.2c07286 · Cited by 145
Triggering antitumoural drug release and gene expression by magnetic hyperthermia
Moros, M., Idiago-López, J., Asín, L., Antolín, E. M., Beola, L., Grazú, V., Fratila, R. M., Gutiérrez, L., & de la Fuente, J. M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.004 · Cited by 144
Recent Advances in Functionalized Nanoparticles in Cancer Theranostics
Siddique, S., & Chow, J. C. L. (2022) · Nanomaterials · doi:10.3390/nano12162826 · Cited by 147
Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery
Tenchov, R., Hughes, K. J., Ganesan, M., Iyer, K. A., Ralhan, K., Diaz, L. M. L., Bird, R. E., Ivanov, J. M., & Zhou, Q. A. (2025) · ACS Nano · doi:10.1021/acsnano.4c09566 · Cited by 153
Fusco, L., Gazzi, A., Peng, G., Shin, Y., Vranic, S., Bedognetti, D., Vitale, F., Yılmazer, A., Feng, X., Fadeel, B., et al. (2020) · Theranostics · doi:10.7150/thno.40068 · Cited by 140
3D Printing and Nanotechnology: A Multiscale Alliance in Personalized Medicine
dos Santos, J., de Oliveira, R. S., de Oliveira, T. V., Velho, M. C., Konrad, M. V., da Silva, G. S., Deon, M., & Beck, R. C. R. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009691 · Cited by 146
Abdel-Mageed, H. M., AbuelEzz, N. Z., Radwan, R. A., & Mohamed, S. A. (2021) · Journal of Microencapsulation · doi:10.1080/02652048.2021.1942275 · Cited by 145
Páscoli, M., Lopes-Oliveira, P. J., Fraceto, L. F., Seabra, A. B., & Oliveira, H. C. (2018) · Energy Ecology and Environment · doi:10.1007/s40974-018-0090-2 · Cited by 139
Nunes, Y. L., de Menezes, F. L., de Sousa, I. G., Cavalcante, A. L. G., Cavalcante, F. T. T., Moreira, K. D. S., de Oliveira, A. L. B., Mota, G. F., Souza, J. E. D. S., Falcão, Í. R. D. A., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.04.004 · Cited by 140
Muro-Cruces, J., Roca, A. G., López‐Ortega, A., Fantechi, E., del-Pozo-Bueno, D., Estradé, S., Peiró, F., Sepúlveda, B., Pineider, F., Sangregorio, C., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b01281 · Cited by 135
Current regulatory landscape of nanomaterials and nanomedicines: A global perspective
Ali, F., Neha, K., & Parveen, S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104118 · Cited by 144
Improvement of Hyperthermia Properties of Iron Oxide Nanoparticles by Surface Coating
Vassallo, M., Martella, D., Barrera, G., Celegato, F., Coïsson, M., Ferrero, R., Olivetti, E. S., Troia, A., Sozeri, H., Parmeggiani, C., et al. (2023) · ACS Omega · doi:10.1021/acsomega.2c06244 · Cited by 137
Combining multi-scale 3D printing technologies to engineer reinforced hydrogel-ceramic interfaces
Diloksumpan, P., de Ruijter, M., Castilho, M. D., Gbureck, U., Vermonden, T., van Weeren, P. R., Malda, J., & Levato, R. (2020) · Biofabrication · doi:10.1088/1758-5090/ab69d9 · Cited by 136
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine
La-Beck, N. M., Islam, M. R., & Markiewski, M. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603039 · Cited by 139
Recent Advances in the Generation of Antibody–Nanomaterial Conjugates
Sivaram, A. J., Wardiana, A., Howard, C. B., Mahler, S. M., & Thurecht, K. J. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700607 · Cited by 139
Self-citationThe potential anti‐infective applications of metal oxide nanoparticles: A systematic review
Abo‐zeid, Y., & Williams, G. R. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1592 · Cited by 140
Advancement in nanogel formulations provides controlled drug release
Ahmed, S., Alhareth, K., & Mignet, N. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119435 · Cited by 139
Alavi, M., Karimi, N., & Valadbeigi, T. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00274 · Cited by 134
Ultrasmall-in-Nano Approach: Enabling the Translation of Metal Nanomaterials to Clinics
Cassano, D., Pocoví‐Martínez, S., & Voliani, V. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00664 · Cited by 134
Transforming nanomedicine manufacturing toward Quality by Design and microfluidics
Colombo, S., Beck‐Broichsitter, M., Boetker, J. P., Malmsten, M., Rantanen, J., & Bohr, A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.004 · Cited by 141
Yuba, E. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02470k · Cited by 134
Francia, V., Montizaan, D., & Salvati, A. L. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.25 · Cited by 142
Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer
Liu, X., Wang, J., Ashby, C. R., Zeng, L., Fan, Y., & Chen, Z. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.030 · Cited by 140
Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials
Krasteva, N. A., & Georgieva, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061213 · Cited by 148
Organ‐on‐a‐Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine
Rodrigues, R. O., Sousa, P. C., Gaspar, J., Bañobre‐López, M., Lima, R. A., & Minas, G. M. H. (2020) · Small · doi:10.1002/smll.202003517 · Cited by 134
Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation
González‐Valdivieso, J., Girotti, A., Schneider, J., & Arias, F. J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120438 · Cited by 138
Delivery of cancer therapies by synthetic and bio-inspired nanovectors
Briolay, T., Petithomme, T., Fouet, M., Nguyen-Pham, N., Blanquart, C., & Boisgerault, N. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01346-2 · Cited by 142
Kopec̆ek, J., & Yang, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.020 · Cited by 133
Liposomes: Biomedical Applications
Kim, E., & Jeong, H. (2021) · Chonnam Medical Journal · doi:10.4068/cmj.2021.57.1.27 · Cited by 134
Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment
Bariwal, J. B., Ma, H., Altenberg, G. A., & Liang, H. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01074c · Cited by 130
Solid nanoparticles for oral antimicrobial drug delivery: a review
Raza, A., Sime, F. B., Cabot, P. J., Maqbool, F., Roberts, J. A., & Falconer, J. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.01.004 · Cited by 128
Self-Assembled Organic Nanomaterials for Drug Delivery, Bioimaging, and Cancer Therapy
Zhang, Y., Fang, F., Li, L., & Zhang, J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00883 · Cited by 129
Microfluidic Manufacture of Lipid-Based Nanomedicines
Osouli-Bostanabad, K., Puliga, S., Serrano, D. R., Bucchi, A., Halbert, G., & Lalatsa, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091940 · Cited by 137
Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics
Hatami, E., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188381 · Cited by 127
Lipid polymer hybrid nanoparticles as potent vehicles for drug delivery in cancer therapeutics
Parveen, S., Gupta, P., Kumar, S., & Banerjee, M. (2023) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2023.100165 · Cited by 131
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
Jin, Y., Huang, Y., Ren, H., Huang, H., Lai, C., Wang, W., Tong, Z., Zhang, H., Wu, W., Liu, C., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2023.122463 · Cited by 130
Drug Delivery with Designed Peptide Assemblies
Sis, M. J., & Webber, M. J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.08.003 · Cited by 125
Thioether Phosphatidylcholine Liposomes: A Novel ROS-Responsive Platform for Drug Delivery
Du, Y., He, W., Xia, Q., Zhou, W., Yao, C., & Li, X. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b08901 · Cited by 125
Clinical applications of nanomedicine in cancer therapy
Norouzi, M., Amerian, M., Amerian, M., & Atyabi, F. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.017 · Cited by 126
Nanotoxicology and nanomedicine: The Yin and Yang of nano-bio interactions for the new decade
Bondarenko, O. M., Mortimer, M., Kahru, A., Feliu, N., Javed, I., Käkinen, A., Lin, S., Xia, T., Song, Y., Davis, T. P., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101184 · Cited by 127
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
Recent advances in nanotherapeutic strategies for spinal cord injury repair
Song, Y. H., Agrawal, N. K., Griffin, J. M., & Schmidt, C. E. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.011 · Cited by 124
Sábio, R. M., Meneguin, A. B., Ribeiro, T. D. C., da Silva, R. R., & Chorilli, M. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.067 · Cited by 126
Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy
Yang, K., Yang, Z., Yu, G., Nie, Z., Wang, R., & Chen, X. S. (2021) · Advanced Materials · doi:10.1002/adma.202107434 · Cited by 124
Wang, D., Yu, C., Xu, L., Shi, L., Tong, G., Wu, J., Liu, H. S., Yan, D., & Zhu, X. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b04556 · Cited by 123
Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines
Albalawi, F., Hussein, M. Z., Fakurazi, S., & Masarudin, M. J. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s288236 · Cited by 129
Design Strategies and Applications of ROS-Responsive Phenylborate Ester-Based Nanomedicine
Liu, Y., Liu, Y., Zang, J., Abdullah, A. A. I., Li, Y., & Dong, H. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01190 · Cited by 122
Controlled radical polymerization in dispersed systems for biological applications
Gurnani, P., & Perrier, S. (2020) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2020.101209 · Cited by 122
Skin microbiota analysis-inspired development of novel anti-infectives
Liu, Y., Liu, Y., Du, Z., Zhang, L., Chen, J., Shen, Z., Liu, Q., Qin, J., Lv, H., Wang, H., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00866-1 · Cited by 125
Smart nanocarriers-based drug delivery for cancer therapy: An innovative and developing strategy
Huda, S., Alam, A., & Sharma, P. K. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102018 · Cited by 123
Antiviral nanoparticles for sanitizing surfaces: A roadmap to self-sterilizing against COVID-19
Lin, N., Verma, D., Saini, N., Arbi, R. I., Munir, M., Jović, M., & Turak, A. Z. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101267 · Cited by 127
Mills, J. A., Liu, F., Jarrett, T. R., Fletcher, N. L., & Thurecht, K. J. (2022) · Biomaterials Science · doi:10.1039/d2bm00181k · Cited by 128
Self-citationHawthorne, D., Pannala, A. S., Sandeman, S. R., & Lloyd, A. W. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103936 · Cited by 127
Tseu, G. Y. W., & Kamaruzaman, K. A. (2023) · Molecules · doi:10.3390/molecules28031498 · Cited by 125
Hurst, P. J., Rakowski, A. M., & Patterson, J. P. (2020) · Nature Communications · doi:10.1038/s41467-020-18460-2 · Cited by 123
Interaction of nanoparticles with biological macromolecules: a review of molecular docking studies
Abdelsattar, A. S., Dawoud, A., & Helal, M. A. (2020) · Nanotoxicology · doi:10.1080/17435390.2020.1842537 · Cited by 120
Nanoparticles in the diagnosis and treatment of vascular aging and related diseases
Xu, H., Li, S., & Liu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01082-z · Cited by 130
Stimuli-responsive structure–property switchable polymer materials
Png, Z. M., Wang, C., Yeo, J. C. C., Lee, J. J. C., Surat’man, N. E. B., Tan, Y. L., Liu, H., Wang, P., Tan, B. H., Xu, J. W., et al. (2023) · Molecular Systems Design & Engineering · doi:10.1039/d3me00002h · Cited by 119
Yang, H., Yao, X., Liu, Y., Shen, X., Li, M., & Luo, Z. Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c04632 · Cited by 122
Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges
Saleem, K., Khursheed, Z., Hano, C., Anjum, I., & Anjum, S. (2019) · Nanomaterials · doi:10.3390/nano9121749 · Cited by 118
The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles
García-Mouton, C., Hidalgo, A., Cruz, A., & Pérez‐Gil, J. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.09.020 · Cited by 121
Xiong, X., Xu, Z., Huang, H., Wang, Y., Zhao, J., Guo, X., & Zhou, S. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119840 · Cited by 118
Metadata
- Authors
- Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R.
- Affiliations
- The University of Queensland (AU)
- Monash University (AU)
- Corresponding author
- Corrie, Simon R.
- Venue
- Pharmaceutical Research
- Published
- 2016-06-14
- Volume
- 33
- Issue
- 10
- Pages
- 2373-2387
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2421275313
- Cited by
- 2,586
- References
- 94
- Citations by year
- 2026: 173 · 2025: 202 · 2024: 218 · 2023: 250 · 2022: 302 · 2021: 382 · 2020: 391 · 2019: 323 · 2018: 234 · 2017: 96 · 2016: 12
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centre of Excellence in Convergent BioNano Science and Technology (CE140100036)
- National Health and Medical Research Council (APP1099231)
- Australian Research Council (FT110100284, DP140100951)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › General Materials Science › Nanotechnology research and applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- nanomedicine, nanoparticle drug delivery, liposomes, polymeric nanoparticles, nanocrystals, micelles, protein nanoparticles, inorganic nanoparticles, metal nanoparticles, theranostics, active targeting, nanomaterial classification, regulatory approval
- MeSH terms
- Clinical Trials as Topic, Humans, Tissue Distribution, United States, Drug Approval, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review